Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.90x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/S 4.51x
$28.02Latest market snapshot
Implied fair value · at ELAN's multiple
$16.1442.4% below market
6.22 ACAD revenue / share×2.60x ELAN P/S=$16.14
Market $28.02Implied $16.14
ELAN · current priceP/S 2.60x
$24.50Latest market snapshot
Implied fair value · at ACAD's multiple
$42.5273.6% above market
9.44 ELAN revenue / share×4.51x ACAD P/S=$42.52
Market $24.50Implied $42.52